| (+)-alpha-tocopherol | multiple interactions | ISO | RGD:736021 | 6480464 | alpha-Tocopherol inhibits the reaction [APP protein results in increased activity of MAPK14 protein]; more ... | CTD | PMID:12684028 |
| (+)-catechin | decreases response to substance | EXP | | 6480464 | Catechin results in decreased susceptibility to APP protein | CTD | PMID:15134381 |
| (+)-catechin | multiple interactions | EXP | | 6480464 | resveratrol promotes the reaction [Catechin results in decreased susceptibility to APP protein] | CTD | PMID:15134381 |
| (24S)-24-hydroxycholesterol | multiple interactions | ISO | RGD:736021 | 6480464 | 24-hydroxycholesterol results in decreased metabolism of and results in decreased secretion of APP protein | CTD | PMID:15148325 |
| (24S)-24-hydroxycholesterol | multiple interactions | ISO | RGD:736021 | 6480464 | 24-hydroxycholesterol affects the metabolism of and results in increased activity of APP protein | CTD | PMID:17532301 |
| (24S)-24-hydroxycholesterol | increases metabolic processing | ISO | RGD:736021 | 6480464 | 24-hydroxycholesterol results in increased metabolism of APP protein | CTD | PMID:19126211 |
| (2R,3R,4R,5S)-2-(hydroxymethyl)piperidine-3,4,5-triol | decreases response to substance | ISO | RGD:736022 | 6480464 | 1-Deoxynojirimycin results in decreased susceptibility to APP protein | CTD | PMID:19028522 |
| (S)-naringenin | multiple interactions | EXP | | 6480464 | naringenin inhibits the reaction [APP protein modified form results in increased abundance of Reactive Oxygen Species] | CTD | PMID:15030205 |
| (S)-nicotine | multiple interactions | ISO | RGD:736021 | 6480464 | Bungarotoxins inhibits the reaction [Nicotine inhibits the reaction [Copper results in increased expression of APP protein]]; more ... | CTD | PMID:16627626 |
| (S)-nicotine | multiple interactions | EXP | | 6480464 | APP protein modified form inhibits the reaction [Nicotine results in increased secretion of Acetylcholine]; more ... | CTD | PMID:16474004 |
| (S)-nicotine | decreases expression | ISO | RGD:736022 | 6480464 | Nicotine results in decreased expression of APP protein alternative form | CTD | PMID:17135361 |
| (S)-nicotine | decreases expression | ISO | RGD:736021 | 6480464 | Nicotine results in decreased expression of APP mRNA; more ... | CTD | PMID:16627626 |
| 17alpha-ethynylestradiol | decreases expression | ISO | RGD:736022 | 6480464 | Ethinyl Estradiol results in decreased expression of APP mRNA | CTD | PMID:19400957 |
| 17alpha-ethynylestradiol | decreases expression | EXP | | 6480464 | Ethinyl Estradiol results in decreased expression of APP mRNA | CTD | PMID:19400957 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:736022 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of APP mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:736022 | 6480464 | Ethinyl Estradiol results in increased expression of APP mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:736022 | 6480464 | Ethinyl Estradiol affects the expression of APP mRNA | CTD | PMID:17555576 |
| 17beta-estradiol | multiple interactions | ISO | RGD:736021 | 6480464 | Estradiol inhibits the reaction [Cobalt results in increased secretion of APP protein modified form]; more ... | CTD | PMID:12182891 |
| 17beta-estradiol | decreases expression | ISO | RGD:736022 | 6480464 | Estradiol results in decreased expression of APP mRNA | CTD | PMID:22467019 |
| 17beta-estradiol | multiple interactions | ISO | RGD:736021 | 6480464 | Estradiol inhibits the reaction [APP protein results in increased activity of CASP3 protein] | CTD | PMID:12963085 |
| 17beta-hydroxy-5alpha-androstan-3-one | decreases expression | ISO | RGD:736022 | 6480464 | Dihydrotestosterone results in decreased expression of APP mRNA | CTD | PMID:17023530 |
| 2,2,2-tetramine | multiple interactions | ISO | RGD:736021 | 6480464 | Trientine inhibits the reaction [[[[APP protein modified form binds to Copper] which co-treated with Ascorbic Acid] results in increased oxidation of phosphatidylcholine hydroperoxide] which results in increased chemical synthesis of 4-hydroxy-2-nonenal]; more ... | CTD | PMID:17964426 |
| 2,2,2-tetramine | multiple interactions | ISO | RGD:736021 | 6480464 | Trientine inhibits the reaction [APP protein results in increased activity of CASP3 protein] | CTD | PMID:12963085 |
| 2,2,2-tetramine | increases metabolic processing | ISO | RGD:736021 | 6480464 | Trientine results in increased metabolism of APP protein | CTD | PMID:10940226 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:736022 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of APP mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:736022 | 6480464 | Tetrachlorodibenzodioxin affects the expression of APP mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:736022 | 6480464 | Tetrachlorodibenzodioxin affects the reaction [AHR protein binds to APP promoter] | CTD | PMID:19654925 |
| 2,4-dinitrophenol | affects localization | ISO | RGD:736022 | 6480464 | 2,4-Dinitrophenol affects the localization of APP protein | CTD | PMID:18949129 |
| 2,4-dinitrophenol | multiple interactions | ISO | RGD:736022 | 6480464 | 2,4-Dinitrophenol affects the reaction [APP protein affects the abundance of Calcium] | CTD | PMID:18949129 |
| 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of APP mRNA | CTD | PMID:21346803 |
| 2-deoxy-D-glucose | multiple interactions | ISO | RGD:736021 | 6480464 | [Sodium Azide co-treated with Deoxyglucose] affects the cleavage of and affects the localization of APP protein | CTD | PMID:17405930 |
| 2-ethoxyethanol | increases expression | EXP | | 6480464 | 2-ethoxyethanol results in increased expression of APP mRNA | CTD | PMID:19643169 |
| 2-methoxyethanol | increases expression | EXP | | 6480464 | methyl cellosolve results in increased expression of APP mRNA | CTD | PMID:19643169 |
| 26-hydroxycholesterol | multiple interactions | ISO | RGD:736021 | 6480464 | 27-hydroxycholesterol results in decreased metabolism of and results in decreased secretion of APP protein | CTD | PMID:15148325 |
| 26-hydroxycholesterol | decreases secretion | ISO | RGD:736021 | 6480464 | 27-hydroxycholesterol results in decreased secretion of APP protein alternative form | CTD | PMID:19158428 |
| 26-hydroxycholesterol | increases expression | ISO | RGD:736021 | 6480464 | 27-hydroxycholesterol results in increased expression of APP protein alternative form | CTD | PMID:19126211 |
| 3,3',5,5'-tetrabromobisphenol A | increases secretion | ISO | RGD:736021 | 6480464 | tetrabromobisphenol A results in increased secretion of APP protein modified form | CTD | PMID:22485137 |
| 3,3',5-triiodo-L-thyronine | decreases expression | ISO | RGD:736021 | 6480464 | Triiodothyronine results in decreased expression of APP mRNA; more ... | CTD | PMID:17199430 |
| 3,3',5-triiodo-L-thyronine | multiple interactions | ISO | RGD:736021 | 6480464 | Tretinoin promotes the reaction [Triiodothyronine results in decreased secretion of APP protein] | CTD | PMID:17199430 |
| 3-nitrophenol | affects localization | ISO | RGD:736022 | 6480464 | 3-nitrophenol affects the localization of APP protein | CTD | PMID:18949129 |
| 3-nitrophenol | multiple interactions | ISO | RGD:736022 | 6480464 | 3-nitrophenol affects the reaction [APP protein affects the abundance of Calcium] | CTD | PMID:18949129 |
| 3H-1,2-dithiole-3-thione | decreases expression | EXP | | 6480464 | 1,2-dithiol-3-thione results in decreased expression of APP mRNA | CTD | PMID:19162173 |
| 4-hydroxynon-2-enal | multiple interactions | ISO | RGD:736021 | 6480464 | [[[APP protein modified form binds to Copper] which co-treated with Ascorbic Acid] results in increased oxidation of phosphatidylcholine hydroperoxide] which results in increased chemical synthesis of 4-hydroxy-2-nonenal; more ... | CTD | PMID:17964426 |
| 4-hydroxynon-2-enal | decreases expression | ISO | RGD:736021 | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of APP mRNA | CTD | PMID:12419474 |
| 4-phenylbutyric acid | affects activity | EXP | | 6480464 | 4-phenylbutyric acid affects the activity of APP protein | CTD | PMID:16204253 |
| 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide | decreases expression | ISO | RGD:736021 | 6480464 | AICA ribonucleotide results in decreased expression of APP protein modified form | CTD | PMID:20080969 |
| 5-azacytidine | decreases methylation | ISO | RGD:736022 | 6480464 | Azacitidine results in decreased methylation of APP promoter | CTD | PMID:19635394 |
| 5-azacytidine | multiple interactions | ISO | RGD:736022 | 6480464 | Betaine inhibits the reaction [Azacitidine results in decreased methylation of APP promoter]; more ... | CTD | PMID:19635394 |
| 7alpha-hydroxycholesterol | increases chemical synthesis | EXP | | 6480464 | APP protein results in increased chemical synthesis of cholest-5-en-3 beta,7 alpha-diol | CTD | PMID:15591071 |
| 7alpha-hydroxycholesterol | decreases secretion | EXP | | 6480464 | cholest-5-en-3 beta,7 alpha-diol results in decreased secretion of APP protein | CTD | PMID:15591071 |
| 9-cis-retinoic acid | multiple interactions | ISO | RGD:736021 | 6480464 | alitretinoin inhibits the reaction [Flurbiprofen results in decreased secretion of APP protein] | CTD | PMID:19659691 |
| acetyl-CoA | affects localization | ISO | RGD:736022 | 6480464 | APP protein affects the localization of Acetyl Coenzyme A | CTD | PMID:16122837 |
| acetyl-CoA | multiple interactions | ISO | RGD:736022 | 6480464 | IL1B protein affects the reaction [APP protein affects the localization of Acetyl Coenzyme A] | CTD | PMID:16122837 |
| acetylcholine | multiple interactions | ISO | RGD:736022 | 6480464 | [IL1B protein co-treated with APP protein] results in increased secretion of Acetylcholine; more ... | CTD | PMID:16122837 |
| acetylcholine | decreases secretion | ISO | RGD:736022 | 6480464 | APP protein results in decreased secretion of Acetylcholine | CTD | PMID:16122837 |
| acetylcholine | multiple interactions | EXP | | 6480464 | APP protein modified form inhibits the reaction [Nicotine results in increased secretion of Acetylcholine]; more ... | CTD | PMID:16474004 |
| acrolein | multiple interactions | ISO | RGD:736021 | 6480464 | Acrolein promotes the reaction [APP protein binds to APP protein]; more ... | CTD | PMID:16081039 |
| acrolein | affects binding | ISO | RGD:736021 | 6480464 | Acrolein binds to APP protein; more ... | CTD | PMID:16081039 |
| aflatoxin B1 | decreases expression | ISO | RGD:736022 | 6480464 | Aflatoxin B1 results in decreased expression of APP mRNA | CTD | PMID:19770486 |
| aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of APP mRNA | CTD | PMID:22484513 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:736021 | 6480464 | [BDNF protein co-treated with Tretinoin] results in increased expression of APP protein; more ... | CTD | PMID:16150056 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | Tretinoin inhibits the reaction [Vitamin A affects the expression of APP mRNA] | CTD | PMID:16530976 |
| all-trans-retinoic acid | increases secretion | ISO | RGD:736021 | 6480464 | Tretinoin results in increased secretion of APP protein modified form | CTD | PMID:19476501 |
| all-trans-retinoic acid | increases expression | ISO | RGD:736021 | 6480464 | Tretinoin results in increased expression of APP protein | CTD | PMID:16150056 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:736021 | 6480464 | Tretinoin promotes the reaction [Triiodothyronine results in decreased secretion of APP protein] | CTD | PMID:17199430 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:736021 | 6480464 | Go 6976 inhibits the reaction [Tretinoin results in increased secretion of APP protein modified form] | CTD | PMID:19476501 |
| all-trans-retinol | multiple interactions | EXP | | 6480464 | Tretinoin inhibits the reaction [Vitamin A affects the expression of APP mRNA] | CTD | PMID:16530976 |
| all-trans-retinol | affects expression | EXP | | 6480464 | Vitamin A affects the expression of APP mRNA | CTD | PMID:16530976 |
| alpha-hexachlorocyclohexane | increases expression | EXP | | 6480464 | alpha-hexachlorocyclohexane results in increased expression of APP mRNA | CTD | PMID:17785943 |
| aluminium atom | affects binding | ISO | RGD:736021 | 6480464 | APP protein binds to Aluminum | CTD | PMID:16942756 |
| aluminium atom | increases expression | ISO | RGD:736021 | 6480464 | Aluminum results in increased expression of APP mRNA | CTD | PMID:16308480 |
| aluminium atom | multiple interactions | ISO | RGD:736022 | 6480464 | meloxicam inhibits the reaction [Aluminum results in increased expression of APP protein] | CTD | PMID:16928369 |
| aluminium atom | multiple interactions | ISO | RGD:736022 | 6480464 | Vitamin E inhibits the reaction [Aluminum results in increased cleavage of APP protein] | CTD | PMID:12039845 |
| aluminium atom | multiple interactions | ISO | RGD:736022 | 6480464 | APP protein promotes the reaction [Aluminum results in decreased activity of CHAT protein] | CTD | PMID:16724269 |
| aluminium atom | increases expression | ISO | RGD:736022 | 6480464 | Aluminum results in increased expression of APP protein | CTD | PMID:16928369 |
| aluminium atom | increases cleavage | ISO | RGD:736022 | 6480464 | Aluminum results in increased cleavage of APP protein | CTD | PMID:12039845 |
| aluminium trichloride | increases response to substance | ISO | RGD:736021 | 6480464 | aluminum chloride results in increased susceptibility to APP protein modified form | CTD | PMID:20111991 |
| aluminium trichloride | multiple interactions | ISO | RGD:736022 | 6480464 | caffeic acid inhibits the reaction [aluminum chloride results in increased expression of APP protein]; more ... | CTD | PMID:18482095 |
| aluminium trichloride | increases expression | ISO | RGD:736022 | 6480464 | aluminum chloride results in increased expression of APP protein; more ... | CTD | PMID:18482095 |
| aluminium trichloride | multiple interactions | ISO | RGD:736021 | 6480464 | [aluminum chloride co-treated with APP protein modified form] results in decreased expression of BACE1 mRNA; more ... | CTD | PMID:20111991 |
| aluminium trichloride | increases expression | EXP | | 6480464 | aluminum chloride results in increased expression of APP protein | CTD | PMID:19818510 |
| aluminium trichloride | increases expression | EXP | | 6480464 | aluminum chloride results in increased expression of APP mRNA | CTD | PMID:19818510 PMID:20568471 |
| aluminium(0) | affects binding | ISO | RGD:736021 | 6480464 | APP protein binds to Aluminum | CTD | PMID:16942756 |
| aluminium(0) | increases expression | ISO | RGD:736021 | 6480464 | Aluminum results in increased expression of APP mRNA | CTD | PMID:16308480 |
| aluminium(0) | multiple interactions | ISO | RGD:736022 | 6480464 | meloxicam inhibits the reaction [Aluminum results in increased expression of APP protein] | CTD | PMID:16928369 |
| aluminium(0) | multiple interactions | ISO | RGD:736022 | 6480464 | Vitamin E inhibits the reaction [Aluminum results in increased cleavage of APP protein] | CTD | PMID:12039845 |
| aluminium(0) | multiple interactions | ISO | RGD:736022 | 6480464 | APP protein promotes the reaction [Aluminum results in decreased activity of CHAT protein] | CTD | PMID:16724269 |
| aluminium(0) | increases expression | ISO | RGD:736022 | 6480464 | Aluminum results in increased expression of APP protein | CTD | PMID:16928369 |
| aluminium(0) | increases cleavage | ISO | RGD:736022 | 6480464 | Aluminum results in increased cleavage of APP protein | CTD | PMID:12039845 |
| ambenonium chloride | affects cleavage | EXP | | 6480464 | Ambenonium Chloride affects the cleavage of APP protein | CTD | PMID:11099780 |
| amitrole | affects activity | EXP | | 6480464 | Amitrole affects the activity of APP protein | CTD | PMID:16204253 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of APP mRNA | CTD | PMID:16483693 |
| ammonium chloride | decreases expression | EXP | | 6480464 | Ammonium Chloride results in decreased expression of APP protein | CTD | PMID:16483693 |
| anandamide | decreases response to substance | EXP | | 6480464 | anandamide results in decreased susceptibility to APP protein | CTD | PMID:22233683 |
| astaxanthin | multiple interactions | ISO | RGD:736022 | 6480464 | astaxanthine inhibits the reaction [LEPR gene mutant form results in increased expression of APP mRNA] | CTD | PMID:16964424 |
| baicalein | multiple interactions | EXP | | 6480464 | baicalein inhibits the reaction [APP protein binds to APP protein] | CTD | PMID:17323972 |
| benzene | multiple interactions | ISO | RGD:736021 | 6480464 | Benzene analog inhibits the reaction [APP protein binds to APP protein] | CTD | PMID:15707952 |
| benzene | affects binding | ISO | RGD:736021 | 6480464 | Benzene analog binds to APP protein | CTD | PMID:15707952 |
| benzo[a]pyrene | decreases expression | ISO | RGD:736022 | 6480464 | Benzo(a)pyrene results in decreased expression of APP mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | increases expression | ISO | RGD:736021 | 6480464 | Benzo(a)pyrene results in increased expression of APP mRNA | CTD | PMID:22316170 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:736022 | 6480464 | Benzo(a)pyrene promotes the reaction [AHR protein binds to APP promoter] | CTD | PMID:19654925 |
| bethanechol | increases secretion | EXP | | 6480464 | Bethanechol results in increased secretion of APP protein modified form | CTD | PMID:7605915 PMID:8624119 |
| bilobalide | multiple interactions | ISO | RGD:736021 | 6480464 | bilobalide inhibits the reaction [APP protein results in decreased phosphorylation of CREB1 protein] | CTD | PMID:18001288 |
| bis(2-chloroethyl) sulfide | decreases expression | ISO | RGD:736022 | 6480464 | Mustard Gas results in decreased expression of APP mRNA | CTD | PMID:15674843 |
| bisdemethoxycurcumin | multiple interactions | ISO | RGD:736021 | 6480464 | [bis(4-hydroxycinnamoyl)methane analog co-treated with APP protein] results in increased expression of TLR2 mRNA; more ... | CTD | PMID:22029407 |
| bisdemethoxycurcumin | multiple interactions | ISO | RGD:736021 | 6480464 | bis(4-hydroxycinnamoyl)methane inhibits the reaction [APP protein binds to APP protein] | CTD | PMID:19715544 |
| butan-1-ol | multiple interactions | ISO | RGD:736022 | 6480464 | [1-Butanol results in decreased activity of PLD1 protein] which affects the localization of APP protein | CTD | PMID:16449385 |
| cadmium atom | affects binding | ISO | RGD:736021 | 6480464 | Cadmium binds to APP protein | CTD | PMID:16266835 |
| cadmium dichloride | multiple interactions | ISO | RGD:736022 | 6480464 | [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of APP mRNA | CTD | PMID:19840844 |
| calcium atom | multiple interactions | ISO | RGD:736022 | 6480464 | 2,4-Dinitrophenol affects the reaction [APP protein affects the abundance of Calcium]; more ... | CTD | PMID:18949129 |
| calcium atom | increases uptake | EXP | | 6480464 | APP protein results in increased uptake of Calcium | CTD | PMID:12383957 PMID:18648507 |
| calcium atom | multiple interactions | EXP | | 6480464 | Flurbiprofen inhibits the reaction [APP protein results in increased uptake of Calcium]; more ... | CTD | PMID:18648507 |
| calcium atom | multiple interactions | EXP | | 6480464 | EDN3 protein inhibits the reaction [APP protein results in increased uptake of Calcium]; more ... | CTD | PMID:12383957 |
| calcium atom | increases uptake | EXP | | 6480464 | APP protein results in increased uptake of Calcium | CTD | PMID:18648507 PMID:12383957 |
| calcium atom | affects abundance | ISO | RGD:736022 | 6480464 | APP protein affects the abundance of Calcium | CTD | PMID:18949129 |
| calcium(0) | multiple interactions | ISO | RGD:736022 | 6480464 | 2,4-Dinitrophenol affects the reaction [APP protein affects the abundance of Calcium]; more ... | CTD | PMID:18949129 |
| calcium(0) | increases uptake | EXP | | 6480464 | APP protein results in increased uptake of Calcium | CTD | PMID:12383957 PMID:18648507 |
| calcium(0) | multiple interactions | EXP | | 6480464 | Flurbiprofen inhibits the reaction [APP protein results in increased uptake of Calcium]; more ... | CTD | PMID:18648507 |
| calcium(0) | multiple interactions | EXP | | 6480464 | EDN3 protein inhibits the reaction [APP protein results in increased uptake of Calcium]; more ... | CTD | PMID:12383957 |
| calcium(0) | increases uptake | EXP | | 6480464 | APP protein results in increased uptake of Calcium | CTD | PMID:18648507 PMID:12383957 |
| calcium(0) | affects abundance | ISO | RGD:736022 | 6480464 | APP protein affects the abundance of Calcium | CTD | PMID:18949129 |
| carbachol | multiple interactions | ISO | RGD:736022 | 6480464 | Carbachol inhibits the reaction [APP protein modified form results in increased expression of BAX protein]; more ... | CTD | PMID:10758335 |
| carnosine | decreases expression | ISO | RGD:736022 | 6480464 | Carnosine results in decreased expression of APP protein modified form | CTD | PMID:21423579 |
| carvedilol | decreases expression | ISO | RGD:736022 | 6480464 | carvedilol results in decreased expression of APP protein modified form | CTD | PMID:20579773 |
| celecoxib | affects cleavage | ISO | RGD:736022 | 6480464 | celecoxib affects the cleavage of APP protein | CTD | PMID:14690522 |
| chloroquine | affects expression | EXP | | 6480464 | Chloroquine affects the expression of APP mRNA; more ... | CTD | PMID:9690670 |
| chloroquine | increases expression | EXP | | 6480464 | Chloroquine results in increased expression of APP protein | CTD | PMID:8616629 |
| chloroquine | affects localization | EXP | | 6480464 | Chloroquine affects the localization of APP protein | CTD | PMID:7715800 |
| chloroquine | multiple interactions | EXP | | 6480464 | Chloroquine affects the localization of and affects the cleavage of APP protein | CTD | PMID:8787835 |
| cholesterol | multiple interactions | ISO | RGD:736022 | 6480464 | [Copper co-treated with Cholesterol] results in increased expression of APP mRNA | CTD | PMID:17134702 |
| cholesterol | increases oxidation | EXP | | 6480464 | APP protein results in increased oxidation of Cholesterol | CTD | PMID:15591071 |
| choline | multiple interactions | ISO | RGD:736022 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of APP mRNA | CTD | PMID:20938992 |
| cis-caffeic acid | multiple interactions | ISO | RGD:736022 | 6480464 | caffeic acid inhibits the reaction [aluminum chloride results in increased expression of APP protein modified form]; more ... | CTD | PMID:18482095 |
| clofibrate | decreases expression | EXP | | 6480464 | Clofibrate results in decreased expression of APP mRNA | CTD | PMID:15093671 |
| clofibric acid | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of APP mRNA | CTD | PMID:17602206 |
| cobalt atom | increases secretion | ISO | RGD:736021 | 6480464 | Cobalt results in increased secretion of APP protein modified form | CTD | PMID:12182891 |
| cobalt atom | multiple interactions | ISO | RGD:736021 | 6480464 | Estradiol inhibits the reaction [Cobalt results in increased secretion of APP protein modified form] | CTD | PMID:12182891 |
| cobalt dichloride | decreases expression | ISO | RGD:736021 | 6480464 | cobaltous chloride results in decreased expression of APP mRNA | CTD | PMID:19320972 |
| cocaine | decreases expression | EXP | | 6480464 | Cocaine results in decreased expression of APP mRNA | CTD | PMID:17898221 |
| cocaine | increases expression | ISO | RGD:736021 | 6480464 | Cocaine results in increased expression of APP mRNA | CTD | PMID:16710320 PMID:15009677 |
| cocaine | increases expression | ISO | RGD:736021 | 6480464 | Cocaine results in increased expression of APP mRNA | CTD | PMID:15009677 PMID:16710320 |
| coenzyme Q10 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [coenzyme Q10 results in decreased susceptibility to APP protein]; more ... | CTD | PMID:22186599 |
| coenzyme Q10 | decreases response to substance | EXP | | 6480464 | coenzyme Q10 results in decreased susceptibility to APP protein | CTD | PMID:22186599 |
| Congo Red | multiple interactions | EXP | | 6480464 | Congo Red inhibits the reaction [APP protein binds to APP protein] | CTD | PMID:17323972 |
| Congo Red | affects binding | ISO | RGD:736021 | 6480464 | Congo Red binds to APP protein | CTD | PMID:17406451 |
| copper atom | multiple interactions | ISO | RGD:736021 | 6480464 | Bungarotoxins inhibits the reaction [Nicotine inhibits the reaction [Copper results in increased expression of APP protein]]; more ... | CTD | PMID:16627626 |
| copper atom | decreases expression | ISO | RGD:736021 | 6480464 | Copper deficiency results in decreased expression of APP protein | CTD | PMID:14985339 |
| copper atom | increases expression | ISO | RGD:736021 | 6480464 | Copper results in increased expression of APP mRNA | CTD | PMID:16627626 more ... |
| copper atom | decreases expression | ISO | RGD:736021 | 6480464 | Copper deficiency results in decreased expression of APP mRNA | CTD | PMID:14985339 PMID:18248325 |
| copper atom | increases response to substance | ISO | RGD:736021 | 6480464 | APP protein results in increased susceptibility to Copper | CTD | PMID:11784781 |
| copper atom | increases reduction | ISO | RGD:736021 | 6480464 | APP protein modified form results in increased reduction of Copper; more ... | CTD | PMID:12572668 |
| copper atom | multiple interactions | ISO | RGD:736021 | 6480464 | [[APP protein modified form binds to Copper] which co-treated with Ascorbic Acid] results in increased oxidation of phosphatidylcholine hydroperoxide; more ... | CTD | PMID:17964426 |
| copper atom | affects binding | ISO | RGD:736021 | 6480464 | APP protein modified form binds to Copper | CTD | PMID:16404590 |
| copper atom | multiple interactions | ISO | RGD:736021 | 6480464 | APP protein binds to and results in increased reduction of Copper | CTD | PMID:11784781 |
| copper atom | multiple interactions | ISO | RGD:736021 | 6480464 | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [[Clioquinol binds to Copper] which results in increased degradation of APP protein modified form]; more ... | CTD | PMID:18346929 |
| copper atom | multiple interactions | ISO | RGD:736022 | 6480464 | [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of APP mRNA | CTD | PMID:15467011 |
| copper atom | decreases abundance | ISO | RGD:736022 | 6480464 | APP protein results in decreased abundance of Copper | CTD | PMID:12611883 |
| copper atom | multiple interactions | ISO | RGD:736022 | 6480464 | [APP protein co-treated with Copper] results in decreased degradation of GPC1 protein modified form; more ... | CTD | PMID:15677459 |
| copper atom | multiple interactions | ISO | RGD:736021 | 6480464 | Zinc inhibits the reaction [APP protein modified form results in increased reduction of Copper]; more ... | CTD | PMID:12572668 |
| copper atom | increases expression | ISO | RGD:736021 | 6480464 | Copper results in increased expression of APP mRNA | CTD | PMID:16962711 more ... |
| copper atom | increases degradation | ISO | RGD:736021 | 6480464 | Copper results in increased degradation of APP protein modified form | CTD | PMID:18068270 |
| copper atom | increases secretion | ISO | RGD:736021 | 6480464 | Copper deficiency results in increased secretion of APP protein modified form | CTD | PMID:18248325 |
| copper atom | increases expression | ISO | RGD:736021 | 6480464 | Copper deficiency results in increased expression of APP protein modified form | CTD | PMID:18248325 |
| copper atom | decreases expression | ISO | RGD:736021 | 6480464 | Copper deficiency results in decreased expression of APP mRNA | CTD | PMID:18248325 |
| copper atom | multiple interactions | ISO | RGD:736021 | 6480464 | [Copper binds to Thiosemicarbazones analog] results in decreased abundance of [APP protein modified form binds to APP protein modified form] | CTD | PMID:19122148 |
| copper atom | affects cleavage | ISO | RGD:736021 | 6480464 | Copper affects the cleavage of APP protein | CTD | PMID:18248325 |
| copper atom | multiple interactions | ISO | RGD:736021 | 6480464 | [Copper co-treated with APP protein modified form] results in increased abundance of Reactive Oxygen Species | CTD | PMID:21706413 |
| copper atom | affects binding | ISO | RGD:736021 | 6480464 | Copper binds to APP protein mutant form | CTD | PMID:21980910 |
| copper atom | affects binding | ISO | RGD:736021 | 6480464 | Copper binds to APP protein modified form | CTD | PMID:21980910 PMID:22270944 |
| copper atom | increases expression | ISO | RGD:736021 | 6480464 | Copper results in increased expression of APP mRNA | CTD | PMID:18583042 more ... |
| copper atom | increases expression | ISO | RGD:736021 | 6480464 | Copper results in increased expression of APP protein | CTD | PMID:16962711 PMID:16627626 |
| copper atom | increases expression | ISO | RGD:736021 | 6480464 | Copper results in increased expression of APP mRNA | CTD | PMID:18583042 more ... |
| copper atom | affects binding | ISO | RGD:736021 | 6480464 | Copper binds to APP protein | CTD | PMID:17239395 PMID:17119284 |
| copper atom | multiple interactions | ISO | RGD:736021 | 6480464 | CEP-11004 inhibits the reaction [Copper results in increased expression of APP mRNA]; more ... | CTD | PMID:18583042 |
| copper atom | multiple interactions | ISO | RGD:736021 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Clioquinol co-treated with Copper] results in decreased expression of APP protein alternative form]; more ... | CTD | PMID:16648635 |
| copper atom | increases expression | ISO | RGD:736022 | 6480464 | Copper results in increased expression of APP protein | CTD | PMID:16886094 |
| copper atom | multiple interactions | ISO | RGD:736022 | 6480464 | [Copper co-treated with Cholesterol] results in increased expression of APP mRNA | CTD | PMID:17134702 |
| copper atom | increases secretion | ISO | RGD:736022 | 6480464 | APP protein results in increased secretion of Copper | CTD | PMID:16866297 |
| copper atom | multiple interactions | ISO | RGD:736021 | 6480464 | Plant Extracts inhibits the reaction [Copper results in increased expression of APP mRNA]; more ... | CTD | PMID:16962711 |
| copper atom | increases secretion | ISO | RGD:736021 | 6480464 | Copper results in increased secretion of APP protein alternative form | CTD | PMID:16648635 |
| copper atom | increases secretion | ISO | RGD:736021 | 6480464 | Copper results in increased secretion of APP protein | CTD | PMID:16962711 |
| copper atom | increases expression | ISO | RGD:736021 | 6480464 | Copper results in increased expression of APP mRNA | CTD | PMID:16962711 more ... |
| copper atom | increases expression | ISO | RGD:736021 | 6480464 | Copper results in increased expression of APP protein | CTD | PMID:16627626 PMID:16962711 |
| copper atom | multiple interactions | ISO | RGD:736021 | 6480464 | [Copper binds to APP protein alternative form] which results in increased oxidation of Pyrogallol; more ... | CTD | PMID:15699049 |
| copper atom | multiple interactions | ISO | RGD:736021 | 6480464 | Copper binds to and affects the folding of APP protein | CTD | PMID:16325427 |
| copper atom | affects binding | ISO | RGD:736021 | 6480464 | Copper binds to APP protein alternative form | CTD | PMID:15699049 |
| copper atom | affects binding | ISO | RGD:736021 | 6480464 | Copper binds to APP protein | CTD | PMID:17119284 PMID:17239395 |
| copper(0) | multiple interactions | ISO | RGD:736021 | 6480464 | Bungarotoxins inhibits the reaction [Nicotine inhibits the reaction [Copper results in increased expression of APP protein]]; more ... | CTD | PMID:16627626 |
| copper(0) | decreases expression | ISO | RGD:736021 | 6480464 | Copper deficiency results in decreased expression of APP protein | CTD | PMID:14985339 |
| copper(0) | increases expression | ISO | RGD:736021 | 6480464 | Copper results in increased expression of APP mRNA | CTD | PMID:16627626 more ... |
| copper(0) | decreases expression | ISO | RGD:736021 | 6480464 | Copper deficiency results in decreased expression of APP mRNA | CTD | PMID:14985339 PMID:18248325 |
| copper(0) | increases response to substance | ISO | RGD:736021 | 6480464 | APP protein results in increased susceptibility to Copper | CTD | PMID:11784781 |
| copper(0) | increases reduction | ISO | RGD:736021 | 6480464 | APP protein modified form results in increased reduction of Copper; more ... | CTD | PMID:12572668 |
| copper(0) | multiple interactions | ISO | RGD:736021 | 6480464 | [[APP protein modified form binds to Copper] which co-treated with Ascorbic Acid] results in increased oxidation of phosphatidylcholine hydroperoxide; more ... | CTD | PMID:17964426 |
| copper(0) | affects binding | ISO | RGD:736021 | 6480464 | APP protein modified form binds to Copper | CTD | PMID:16404590 |
| copper(0) | multiple interactions | ISO | RGD:736021 | 6480464 | APP protein binds to and results in increased reduction of Copper | CTD | PMID:11784781 |
| copper(0) | multiple interactions | ISO | RGD:736021 | 6480464 | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [[Clioquinol binds to Copper] which results in increased degradation of APP protein modified form]; more ... | CTD | PMID:18346929 |
| copper(0) | multiple interactions | ISO | RGD:736022 | 6480464 | [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of APP mRNA | CTD | PMID:15467011 |
| copper(0) | decreases abundance | ISO | RGD:736022 | 6480464 | APP protein results in decreased abundance of Copper | CTD | PMID:12611883 |
| copper(0) | multiple interactions | ISO | RGD:736022 | 6480464 | [APP protein co-treated with Copper] results in decreased degradation of GPC1 protein modified form; more ... | CTD | PMID:15677459 |
| copper(0) | multiple interactions | ISO | RGD:736021 | 6480464 | Zinc inhibits the reaction [APP protein modified form results in increased reduction of Copper]; more ... | CTD | PMID:12572668 |
| copper(0) | increases expression | ISO | RGD:736021 | 6480464 | Copper results in increased expression of APP mRNA | CTD | PMID:16962711 more ... |
| copper(0) | increases degradation | ISO | RGD:736021 | 6480464 | Copper results in increased degradation of APP protein modified form | CTD | PMID:18068270 |
| copper(0) | increases secretion | ISO | RGD:736021 | 6480464 | Copper deficiency results in increased secretion of APP protein modified form | CTD | PMID:18248325 |
| copper(0) | increases expression | ISO | RGD:736021 | 6480464 | Copper deficiency results in increased expression of APP protein modified form | CTD | PMID:18248325 |
| copper(0) | decreases expression | ISO | RGD:736021 | 6480464 | Copper deficiency results in decreased expression of APP mRNA | CTD | PMID:18248325 |
| copper(0) | multiple interactions | ISO | RGD:736021 | 6480464 | [Copper binds to Thiosemicarbazones analog] results in decreased abundance of [APP protein modified form binds to APP protein modified form] | CTD | PMID:19122148 |
| copper(0) | affects cleavage | ISO | RGD:736021 | 6480464 | Copper affects the cleavage of APP protein | CTD | PMID:18248325 |
| copper(0) | multiple interactions | ISO | RGD:736021 | 6480464 | [Copper co-treated with APP protein modified form] results in increased abundance of Reactive Oxygen Species | CTD | PMID:21706413 |
| copper(0) | affects binding | ISO | RGD:736021 | 6480464 | Copper binds to APP protein mutant form | CTD | PMID:21980910 |
| copper(0) | affects binding | ISO | RGD:736021 | 6480464 | Copper binds to APP protein modified form | CTD | PMID:21980910 PMID:22270944 |
| copper(0) | increases expression | ISO | RGD:736021 | 6480464 | Copper results in increased expression of APP mRNA | CTD | PMID:18583042 more ... |
| copper(0) | increases expression | ISO | RGD:736021 | 6480464 | Copper results in increased expression of APP protein | CTD | PMID:16962711 PMID:16627626 |
| copper(0) | increases expression | ISO | RGD:736021 | 6480464 | Copper results in increased expression of APP mRNA | CTD | PMID:18583042 more ... |
| copper(0) | affects binding | ISO | RGD:736021 | 6480464 | Copper binds to APP protein | CTD | PMID:17239395 PMID:17119284 |
| copper(0) | multiple interactions | ISO | RGD:736021 | 6480464 | CEP-11004 inhibits the reaction [Copper results in increased expression of APP mRNA]; more ... | CTD | PMID:18583042 |
| copper(0) | multiple interactions | ISO | RGD:736021 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Clioquinol co-treated with Copper] results in decreased expression of APP protein alternative form]; more ... | CTD | PMID:16648635 |
| copper(0) | increases expression | ISO | RGD:736022 | 6480464 | Copper results in increased expression of APP protein | CTD | PMID:16886094 |
| copper(0) | multiple interactions | ISO | RGD:736022 | 6480464 | [Copper co-treated with Cholesterol] results in increased expression of APP mRNA | CTD | PMID:17134702 |
| copper(0) | increases secretion | ISO | RGD:736022 | 6480464 | APP protein results in increased secretion of Copper | CTD | PMID:16866297 |
| copper(0) | multiple interactions | ISO | RGD:736021 | 6480464 | Plant Extracts inhibits the reaction [Copper results in increased expression of APP mRNA]; more ... | CTD | PMID:16962711 |
| copper(0) | increases secretion | ISO | RGD:736021 | 6480464 | Copper results in increased secretion of APP protein alternative form | CTD | PMID:16648635 |
| copper(0) | increases secretion | ISO | RGD:736021 | 6480464 | Copper results in increased secretion of APP protein | CTD | PMID:16962711 |
| copper(0) | increases expression | ISO | RGD:736021 | 6480464 | Copper results in increased expression of APP mRNA | CTD | PMID:16962711 more ... |
| copper(0) | increases expression | ISO | RGD:736021 | 6480464 | Copper results in increased expression of APP protein | CTD | PMID:16627626 PMID:16962711 |
| copper(0) | multiple interactions | ISO | RGD:736021 | 6480464 | [Copper binds to APP protein alternative form] which results in increased oxidation of Pyrogallol; more ... | CTD | PMID:15699049 |
| copper(0) | multiple interactions | ISO | RGD:736021 | 6480464 | Copper binds to and affects the folding of APP protein | CTD | PMID:16325427 |
| copper(0) | affects binding | ISO | RGD:736021 | 6480464 | Copper binds to APP protein alternative form | CTD | PMID:15699049 |
| copper(0) | affects binding | ISO | RGD:736021 | 6480464 | Copper binds to APP protein | CTD | PMID:17119284 PMID:17239395 |
| coumestrol | decreases expression | ISO | RGD:736021 | 6480464 | Coumestrol results in decreased expression of APP mRNA | CTD | PMID:19167446 |
| curcumin | multiple interactions | ISO | RGD:736021 | 6480464 | Curcumin affects the reaction [APP protein binds to APP protein] | CTD | PMID:18537544 |
| curcumin | multiple interactions | ISO | RGD:736021 | 6480464 | Curcumin inhibits the reaction [Copper results in increased expression of APP mRNA] | CTD | PMID:18583042 |
| D-penicillamine | multiple interactions | ISO | RGD:736021 | 6480464 | Penicillamine inhibits the reaction [[[[APP protein modified form binds to Copper] which co-treated with Ascorbic Acid] results in increased oxidation of Phosphatidylcholines] which results in increased chemical synthesis of phosphatidylcholine hydroperoxide] | CTD | PMID:17964426 |
| D-penicillamine | multiple interactions | ISO | RGD:736021 | 6480464 | Penicillamine inhibits the reaction [APP protein results in increased activity of CASP3 protein] | CTD | PMID:12963085 |
| D-penicillamine | increases metabolic processing | ISO | RGD:736021 | 6480464 | Penicillamine results in increased metabolism of APP protein | CTD | PMID:10940226 |
| demethoxycurcumin | decreases secretion | ISO | RGD:736021 | 6480464 | demethoxycurcumin results in decreased secretion of APP protein | CTD | PMID:19715544 |
| demethoxycurcumin | multiple interactions | ISO | RGD:736021 | 6480464 | demethoxycurcumin inhibits the reaction [APP protein binds to APP protein] | CTD | PMID:19715544 |
| desferrioxamine B | affects binding | ISO | RGD:736021 | 6480464 | Deferoxamine binds to APP 5' UTR | CTD | PMID:15681799 |
| desferrioxamine B | multiple interactions | ISO | RGD:736021 | 6480464 | Deferoxamine inhibits the reaction [[[[APP protein modified form binds to Copper] which co-treated with Ascorbic Acid] results in increased oxidation of phosphatidylcholine hydroperoxide] which results in increased chemical synthesis of 4-hydroxy-2-nonenal] | CTD | PMID:17964426 |
| desferrioxamine B | multiple interactions | ISO | RGD:736021 | 6480464 | [Deferoxamine binds to APP 5' UTR] which results in decreased secretion of APP protein modified form; more ... | CTD | PMID:15681799 PMID:15681799 |
| dexamethasone | multiple interactions | EXP | | 6480464 | [APP protein alternative form co-treated with Dexamethasone] results in decreased expression of ADAM10 mRNA; more ... | CTD | PMID:22484447 |
| dexamethasone | multiple interactions | EXP | | 6480464 | [APP protein alternative form co-treated with Dexamethasone] results in increased expression of APP mRNA; more ... | CTD | PMID:22484447 PMID:22484447 |
| diarsenic trioxide | increases expression | ISO | RGD:736021 | 6480464 | arsenic trioxide results in increased expression of APP mRNA | CTD | PMID:20458559 |
| dichlorvos | increases secretion | ISO | RGD:736021 | 6480464 | Dichlorvos results in increased secretion of APP protein alternative form | CTD | PMID:11526466 |
| dichlorvos | increases secretion | EXP | | 6480464 | Dichlorvos results in increased secretion of APP protein modified form | CTD | PMID:7605915 PMID:8624119 |
| dimercaprol | multiple interactions | ISO | RGD:736021 | 6480464 | [Dimercaprol binds to APP 5' UTR] which results in decreased expression of APP protein; more ... | CTD | PMID:15681799 PMID:15681799 |
| dimercaprol | affects binding | ISO | RGD:736021 | 6480464 | Dimercaprol binds to APP 5' UTR | CTD | PMID:15681799 |
| dimethylarsinic acid | multiple interactions | ISO | RGD:736021 | 6480464 | Cacodylic Acid results in increased cleavage of and affects the secretion of APP protein mutant form; more ... | CTD | PMID:21440049 |
| dimethylarsinic acid | increases expression | ISO | RGD:736022 | 6480464 | Cacodylic Acid results in increased expression of APP protein | CTD | PMID:21440049 |
| diuron | decreases expression | EXP | | 6480464 | Diuron results in decreased expression of APP mRNA | CTD | PMID:21551480 |
| donepezil hydrochloride | increases abundance | ISO | RGD:736022 | 6480464 | donepezil results in increased abundance of APP protein | CTD | PMID:18061284 |
| donepezil hydrochloride | decreases response to substance | EXP | | 6480464 | donepezil results in decreased susceptibility to APP protein | CTD | PMID:18571635 |
| doxorubicin | affects response to substance | ISO | RGD:736021 | 6480464 | APP protein affects the susceptibility to Doxorubicin | CTD | PMID:17608641 |
| doxorubicin | multiple interactions | ISO | RGD:736021 | 6480464 | TP53 protein affects the reaction [APP protein affects the susceptibility to Doxorubicin] | CTD | PMID:17608641 |
| elemental selenium | decreases expression | ISO | RGD:736021 | 6480464 | Selenium results in decreased expression of APP mRNA | CTD | PMID:19244175 |
| ethylenediaminetetraacetic acid | multiple interactions | ISO | RGD:736021 | 6480464 | Edetic Acid inhibits the reaction [[[[APP protein modified form binds to Copper] which co-treated with Ascorbic Acid] results in increased oxidation of phosphatidylcholine hydroperoxide] which results in increased chemical synthesis of 4-hydroxy-2-nonenal]; more ... | CTD | PMID:17964426 |
| fenofibrate | multiple interactions | ISO | RGD:736021 | 6480464 | Fenofibrate affects the reaction [PSEN1 protein affects the cleavage of APP protein] | CTD | PMID:17962197 |
| flurbiprofen | affects cleavage | ISO | RGD:736022 | 6480464 | Flurbiprofen affects the cleavage of APP protein | CTD | PMID:14690522 |
| flurbiprofen | decreases secretion | ISO | RGD:736021 | 6480464 | Flurbiprofen results in decreased secretion of APP protein | CTD | PMID:17292621 PMID:19659691 |
| flurbiprofen | multiple interactions | ISO | RGD:736021 | 6480464 | alitretinoin inhibits the reaction [Flurbiprofen results in decreased secretion of APP protein]; more ... | CTD | PMID:19659691 |
| flurbiprofen | multiple interactions | EXP | | 6480464 | Flurbiprofen inhibits the reaction [APP protein results in increased uptake of Calcium] | CTD | PMID:18648507 |
| folic acid | multiple interactions | ISO | RGD:736022 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of APP mRNA | CTD | PMID:20938992 |
| fonofos | increases methylation | ISO | RGD:736021 | 6480464 | Fonofos results in increased methylation of APP promoter | CTD | PMID:22847954 |
| fumonisin B1 | increases expression | ISO | RGD:736022 | 6480464 | fumonisin B1 results in increased expression of APP mRNA | CTD | PMID:16221962 |
| glycine betaine | multiple interactions | ISO | RGD:736022 | 6480464 | Betaine inhibits the reaction [Azacitidine results in decreased methylation of APP promoter]; more ... | CTD | PMID:19635394 |
| Goe 6976 | multiple interactions | ISO | RGD:736021 | 6480464 | Go 6976 inhibits the reaction [Phorbol 12,13-Dibutyrate results in increased secretion of APP protein modified form]; more ... | CTD | PMID:19476501 |
| heroin | decreases expression | ISO | RGD:736021 | 6480464 | Heroin results in decreased expression of APP mRNA | CTD | PMID:16710320 |
| hydrogen peroxide | multiple interactions | ISO | RGD:736021 | 6480464 | Hydrogen Peroxide promotes the reaction [[Copper binds to APP protein alternative form] which results in increased oxidation of Pyrogallol] | CTD | PMID:15699049 |
| hydrogen peroxide | affects expression | ISO | RGD:736021 | 6480464 | Hydrogen Peroxide affects the expression of APP protein; more ... | CTD | PMID:21179406 |
| hydrogen peroxide | increases expression | ISO | RGD:736021 | 6480464 | Hydrogen Peroxide results in increased expression of APP mRNA | CTD | PMID:12419474 |
| ibuprofen | affects cleavage | ISO | RGD:736021 | 6480464 | Ibuprofen affects the cleavage of APP protein | CTD | PMID:11700559 PMID:12777371 |
| ibuprofen | affects cleavage | ISO | RGD:736021 | 6480464 | Ibuprofen affects the cleavage of APP protein | CTD | PMID:12777371 PMID:11700559 |
| ibuprofen | multiple interactions | EXP | | 6480464 | Ibuprofen inhibits the reaction [APP protein results in increased uptake of Calcium] | CTD | PMID:18648507 |
| ibuprofen | multiple interactions | ISO | RGD:736022 | 6480464 | Ibuprofen inhibits the reaction [[APP protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; more ... | CTD | PMID:11080519 |
| ibuprofen | decreases expression | ISO | RGD:736021 | 6480464 | Ibuprofen results in decreased expression of APP protein mutant form | CTD | PMID:15817521 |
| ibuprofen | multiple interactions | ISO | RGD:736021 | 6480464 | Ibuprofen inhibits the reaction [[IFNG protein co-treated with IL1B protein] results in increased metabolism of and results in increased secretion of APP protein alternative form]; more ... | CTD | PMID:14586007 |
| indole-3-methanol | affects expression | EXP | | 6480464 | indole-3-carbinol affects the expression of APP mRNA | CTD | PMID:21396975 |
| indomethacin | multiple interactions | ISO | RGD:736021 | 6480464 | Indomethacin inhibits the reaction [APP protein alternative form results in increased expression of IL6 protein] | CTD | PMID:16111494 |
| indomethacin | decreases expression | ISO | RGD:736022 | 6480464 | Indomethacin results in decreased expression of APP protein alternative form | CTD | PMID:15579461 PMID:17627676 |
| indomethacin | multiple interactions | EXP | | 6480464 | Indomethacin inhibits the reaction [APP protein results in increased uptake of Calcium] | CTD | PMID:18648507 |
| indomethacin | decreases expression | ISO | RGD:736022 | 6480464 | Indomethacin results in decreased expression of APP protein alternative form | CTD | PMID:17627676 PMID:15579461 |
| indomethacin | multiple interactions | ISO | RGD:736022 | 6480464 | Indomethacin inhibits the reaction [[APP protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; more ... | CTD | PMID:11080519 |
| indomethacin | multiple interactions | ISO | RGD:736021 | 6480464 | Indomethacin inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased metabolism of and results in increased secretion of APP protein alternative form] | CTD | PMID:14586007 |
| indomethacin | affects cleavage | ISO | RGD:736021 | 6480464 | Indomethacin affects the cleavage of APP protein | CTD | PMID:11700559 |
| iron atom | increases uptake | ISO | RGD:736021 | 6480464 | Iron results in increased uptake of APP protein | CTD | PMID:15993987 |
| iron atom | increases expression | ISO | RGD:736021 | 6480464 | Iron results in increased expression of APP mRNA | CTD | PMID:16308480 |
| isoflurane | multiple interactions | ISO | RGD:736021 | 6480464 | APP protein promotes the reaction [Isoflurane results in increased cleavage of and results in increased activity of CASP3 protein]; more ... | CTD | PMID:17287498 |
| isoflurane | increases expression | ISO | RGD:736021 | 6480464 | Isoflurane results in increased expression of APP protein | CTD | PMID:17223697 |
| isoflurane | multiple interactions | ISO | RGD:736021 | 6480464 | [Isoflurane binds to APP protein] promotes the reaction [APP protein binds to APP protein] | CTD | PMID:17223697 |
| kaempferol | multiple interactions | EXP | | 6480464 | kaempferol inhibits the reaction [APP protein binds to APP protein] | CTD | PMID:17323972 |
| kojic acid | increases expression | ISO | RGD:736021 | 6480464 | kojic acid results in increased expression of APP mRNA | CTD | PMID:16595896 |
| L-ascorbic acid | increases oxidation | ISO | RGD:736021 | 6480464 | APP protein modified form results in increased oxidation of Ascorbic Acid | CTD | PMID:17964426 |
| L-ascorbic acid | multiple interactions | EXP | | 6480464 | Ascorbic Acid inhibits the reaction [APP protein modified form results in increased abundance of Reactive Oxygen Species] | CTD | PMID:15030205 |
| L-ascorbic acid | multiple interactions | ISO | RGD:736021 | 6480464 | [[[APP protein modified form binds to Copper] which co-treated with Ascorbic Acid] results in increased oxidation of phosphatidylcholine hydroperoxide] which results in increased chemical synthesis of 4-hydroxy-2-nonenal; more ... | CTD | PMID:17964426 |
| L-methionine | multiple interactions | ISO | RGD:736022 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of APP mRNA | CTD | PMID:20938992 |
| lactacystin | multiple interactions | ISO | RGD:736021 | 6480464 | lactacystin inhibits the reaction [resveratrol results in decreased secretion of APP protein] | CTD | PMID:16162502 |
| lead diacetate | increases expression | EXP | | 6480464 | lead acetate results in increased expression of APP mRNA; more ... | CTD | PMID:21117136 PMID:22764079 |
| lead diacetate | decreases methylation | EXP | | 6480464 | lead acetate results in decreased methylation of APP promoter | CTD | PMID:21117136 PMID:22764079 |
| lead(0) | affects abundance | EXP | | 6480464 | Lead affects the abundance of APP mRNA; more ... | CTD | PMID:16230335 |
| lead(0) | multiple interactions | EXP | | 6480464 | PRKCD protein promotes the reaction [Lead results in increased localization of APP protein]; more ... | CTD | PMID:20488202 |
| lead(0) | increases localization | EXP | | 6480464 | Lead results in increased localization of APP protein | CTD | PMID:20488202 |
| lead(0) | increases expression | ISO | RGD:736021 | 6480464 | Lead results in increased expression of APP protein | CTD | PMID:21315759 |
| lead(0) | increases expression | ISO | RGD:736021 | 6480464 | Lead results in increased expression of APP mRNA | CTD | PMID:19921347 PMID:21315759 |
| lead(0) | decreases expression | ISO | RGD:736021 | 6480464 | Lead results in decreased expression of APP protein modified form | CTD | PMID:22313790 |
| lead(0) | multiple interactions | EXP | | 6480464 | Lead affects the reaction [APP protein binds to APP protein] | CTD | PMID:16230335 |
| lead(0) | increases expression | ISO | RGD:736021 | 6480464 | Lead results in increased expression of APP mRNA | CTD | PMID:19921347 |
| lithium atom | multiple interactions | ISO | RGD:736022 | 6480464 | Lithium inhibits the reaction [APP protein binds to APP protein] | CTD | PMID:19621015 |
| lithium atom | multiple interactions | EXP | | 6480464 | Lithium inhibits the reaction [APP protein alternative form results in decreased expression of BCL2 protein] | CTD | PMID:10762662 |
| lovastatin | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Lovastatin results in increased secretion of APP protein modified form]; more ... | CTD | PMID:19741129 |
| lovastatin | increases secretion | EXP | | 6480464 | Lovastatin results in increased secretion of APP protein modified form | CTD | PMID:19741129 |
| LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [coenzyme Q10 results in decreased susceptibility to APP protein] | CTD | PMID:22186599 |
| LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Lovastatin results in increased secretion of APP protein modified form] | CTD | PMID:19741129 |
| LY294002 | multiple interactions | ISO | RGD:736021 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Clioquinol co-treated with Copper] results in decreased expression of APP protein alternative form] | CTD | PMID:16648635 |
| manganese atom | increases expression | ISO | RGD:736021 | 6480464 | Manganese results in increased expression of APP mRNA | CTD | PMID:18583042 |
| manganese(0) | increases expression | ISO | RGD:736021 | 6480464 | Manganese results in increased expression of APP mRNA | CTD | PMID:18583042 |
| melatonin | multiple interactions | ISO | RGD:736021 | 6480464 | Melatonin affects the reaction [APP protein binds to APP protein] | CTD | PMID:18537544 |
| melatonin | multiple interactions | ISO | RGD:736021 | 6480464 | Melatonin inhibits the reaction [Mercuric Chloride results in increased secretion of APP protein modified form] | CTD | PMID:10617124 |
| melatonin | decreases expression | ISO | RGD:736022 | 6480464 | Melatonin analog results in decreased expression of APP protein; more ... | CTD | PMID:18231852 |
| memantine | multiple interactions | EXP | | 6480464 | Memantine inhibits the reaction [Streptozocin results in increased expression of APP protein modified form] | CTD | PMID:21290839 |
| mercury atom | multiple interactions | ISO | RGD:736021 | 6480464 | Estradiol inhibits the reaction [Mercury results in increased secretion of APP protein modified form] | CTD | PMID:12182891 |
| mercury atom | increases secretion | ISO | RGD:736021 | 6480464 | Mercury results in increased secretion of APP protein modified form | CTD | PMID:12182891 |
| mercury dichloride | multiple interactions | ISO | RGD:736021 | 6480464 | Melatonin inhibits the reaction [Mercuric Chloride results in increased secretion of APP protein modified form] | CTD | PMID:10617124 |
| mercury dichloride | increases secretion | ISO | RGD:736021 | 6480464 | Mercuric Chloride results in increased secretion of APP protein modified form | CTD | PMID:10617124 |
| mercury(0) | multiple interactions | ISO | RGD:736021 | 6480464 | Estradiol inhibits the reaction [Mercury results in increased secretion of APP protein modified form] | CTD | PMID:12182891 |
| mercury(0) | increases secretion | ISO | RGD:736021 | 6480464 | Mercury results in increased secretion of APP protein modified form | CTD | PMID:12182891 |
| methapyrilene | increases expression | EXP | | 6480464 | Methapyrilene results in increased expression of APP mRNA | CTD | PMID:22484513 |
| methotrexate | decreases expression | ISO | RGD:736021 | 6480464 | Methotrexate results in decreased expression of APP mRNA | CTD | PMID:17400583 |
| minocycline | multiple interactions | ISO | RGD:736022 | 6480464 | Minocycline inhibits the reaction [APP gene mutant form results in increased phosphorylation of EIF2S1 protein] | CTD | PMID:17406652 |
| minocycline | multiple interactions | EXP | | 6480464 | Minocycline inhibits the reaction [APP protein alternative form results in increased activity of CASP12 protein]; more ... | CTD | PMID:17406652 |
| mitomycin C | increases expression | ISO | RGD:736021 | 6480464 | Mitomycin results in increased expression of APP mRNA | CTD | PMID:12760830 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:736021 | 6480464 | Acetylcysteine inhibits the reaction [APP protein results in increased activity of MAPK14 protein]; more ... | CTD | PMID:12684028 |
| N-methyl-N'-nitro-N-nitrosoguanidine | multiple interactions | ISO | RGD:736022 | 6480464 | [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of APP mRNA; more ... | CTD | PMID:19840844 |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of APP mRNA | CTD | PMID:19638242 |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of APP protein | CTD | PMID:20387270 PMID:19542621 |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of APP protein | CTD | PMID:19542621 PMID:20387270 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of APP mRNA | CTD | PMID:17602206 |
| nickel atom | affects binding | ISO | RGD:736021 | 6480464 | Nickel binds to APP protein alternative form | CTD | PMID:15699049 |
| nimodipine | multiple interactions | EXP | | 6480464 | Nimodipine inhibits the reaction [APP protein results in increased uptake of Calcium] | CTD | PMID:12383957 |
| nitric oxide | multiple interactions | ISO | RGD:736022 | 6480464 | Ibuprofen inhibits the reaction [[APP protein co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; more ... | CTD | PMID:11080519 |
| nitroprusside | multiple interactions | ISO | RGD:736022 | 6480464 | APP protein promotes the reaction [Nitroprusside results in decreased activity of CHAT protein] | CTD | PMID:16724269 |
| nitroprusside | decreases secretion | ISO | RGD:736022 | 6480464 | Nitroprusside results in decreased secretion of APP protein alternative form | CTD | PMID:10691295 |
| okadaic acid | multiple interactions | ISO | RGD:736022 | 6480464 | [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of APP mRNA | CTD | PMID:19840844 |
| olanzapine | multiple interactions | EXP | | 6480464 | olanzapine inhibits the reaction [APP protein modified form affects the activity of CAT protein]; more ... | CTD | PMID:15948179 |
| ozone | multiple interactions | ISO | RGD:736021 | 6480464 | [Ozone co-treated with Particulate Matter] results in increased expression of APP protein | CTD | PMID:15513908 |
| parathion | increases methylation | ISO | RGD:736021 | 6480464 | Parathion results in increased methylation of APP promoter | CTD | PMID:22847954 |
| paroxetine | multiple interactions | ISO | RGD:736021 | 6480464 | [Paroxetine binds to APP 5' UTR] which results in decreased secretion of APP protein modified form | CTD | PMID:15681799 PMID:15681799 |
| pentobarbital | affects expression | EXP | | 6480464 | Pentobarbital affects the expression of APP mRNA | CTD | PMID:1306490 |
| pentobarbital | multiple interactions | EXP | | 6480464 | Pentobarbital inhibits the reaction [Pentylenetetrazole results in increased expression of APP mRNA] | CTD | PMID:9720974 |
| perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of APP mRNA | CTD | PMID:19162173 |
| phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of APP mRNA | CTD | PMID:19162173 |
| phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of APP mRNA | CTD | PMID:15093671 PMID:19162173 |
| phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of APP mRNA | CTD | PMID:19162173 PMID:15093671 |
| phlorizin | decreases expression | ISO | RGD:736022 | 6480464 | Phlorhizin results in decreased expression of APP mRNA | CTD | PMID:22538082 |
| phorbol 12,13-dibutanoate | increases secretion | ISO | RGD:736021 | 6480464 | Phorbol 12,13-Dibutyrate results in increased secretion of APP protein modified form | CTD | PMID:19476501 |
| phorbol 12,13-dibutanoate | multiple interactions | ISO | RGD:736021 | 6480464 | Go 6976 inhibits the reaction [Phorbol 12,13-Dibutyrate results in increased secretion of APP protein modified form] | CTD | PMID:19476501 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:736022 | 6480464 | [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of APP mRNA | CTD | PMID:19840844 |
| physostigmine | increases secretion | EXP | | 6480464 | Physostigmine results in increased secretion of APP protein modified form | CTD | PMID:7605915 PMID:8624119 |
| pioglitazone | decreases expression | ISO | RGD:736021 | 6480464 | pioglitazone results in decreased expression of APP protein mutant form | CTD | PMID:15817521 |
| pioglitazone | decreases expression | ISO | RGD:736022 | 6480464 | pioglitazone results in decreased expression of APP protein | CTD | PMID:16407166 |
| pioglitazone | multiple interactions | ISO | RGD:736021 | 6480464 | pioglitazone inhibits the reaction [[IFNG protein co-treated with TNF protein] results in increased metabolism of and results in increased secretion of APP protein alternative form]; more ... | CTD | PMID:14586007 |
| piperidine | multiple interactions | ISO | RGD:736021 | 6480464 | piperidine analog inhibits the reaction [APP protein binds to APP protein]; more ... | CTD | PMID:17681794 |
| piperonyl butoxide | increases expression | EXP | | 6480464 | Piperonyl Butoxide results in increased expression of APP mRNA | CTD | PMID:22484513 |
| pirinixic acid | decreases expression | ISO | RGD:736022 | 6480464 | pirinixic acid results in decreased expression of APP mRNA | CTD | PMID:17426115 |
| pirinixic acid | multiple interactions | EXP | | 6480464 | pirinixic acid inhibits the reaction [APP protein results in decreased activity of CAT protein]; more ... | CTD | PMID:16204253 |
| pirinixic acid | affects activity | EXP | | 6480464 | pirinixic acid affects the activity of APP protein | CTD | PMID:16204253 |
| potassium atom | multiple interactions | EXP | | 6480464 | [Zinc promotes the reaction [APP protein binds to APP protein]] which affects the transport of Potassium | CTD | PMID:16674922 |
| pravastatin | increases expression | ISO | RGD:736021 | 6480464 | Pravastatin results in increased expression of APP | CTD | PMID:19461118 |
| pregnenolone | decreases response to substance | EXP | | 6480464 | Pregnenolone results in decreased susceptibility to APP protein modified form | CTD | PMID:18926803 |
| pregnenolone 16alpha-carbonitrile | increases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in increased expression of APP mRNA | CTD | PMID:19162173 |
| progesterone | decreases metabolic processing | ISO | RGD:736022 | 6480464 | APP gene mutant form results in decreased metabolism of Progesterone metabolite | CTD | PMID:17988898 |
| progesterone | multiple interactions | ISO | RGD:736022 | 6480464 | Progesterone inhibits the reaction [APP gene mutant form results in decreased metabolism of Progesterone metabolite] | CTD | PMID:17988898 |
| propiconazole | increases expression | EXP | | 6480464 | propiconazole results in increased expression of APP mRNA | CTD | PMID:19423681 |
| propofol | multiple interactions | ISO | RGD:736021 | 6480464 | [Propofol binds to APP protein] promotes the reaction [APP protein binds to APP protein] | CTD | PMID:17223697 |
| prostaglandin E2 | increases abundance | EXP | | 6480464 | APP protein modified form results in increased abundance of Dinoprostone | CTD | PMID:20171164 |
| prostaglandin E2 | multiple interactions | EXP | | 6480464 | PTGES2 promotes the reaction [APP protein modified form results in increased abundance of Dinoprostone] | CTD | PMID:20171164 |
| prostaglandin E2 | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [APP protein results in increased secretion of Dinoprostone] | CTD | PMID:16685418 |
| prostaglandin E2 | increases expression | EXP | | 6480464 | Dinoprostone results in increased expression of APP protein modified form | CTD | PMID:20171164 |
| pyrogallol | multiple interactions | ISO | RGD:736021 | 6480464 | [Copper binds to APP protein alternative form] which results in increased oxidation of Pyrogallol; more ... | CTD | PMID:15699049 |
| quercetin | multiple interactions | ISO | RGD:736021 | 6480464 | 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [Quercetin inhibits the reaction [APP protein results in decreased phosphorylation of CREB1 protein]]; more ... | CTD | PMID:18001288 |
| quercetin | multiple interactions | ISO | RGD:736021 | 6480464 | Quercetin inhibits the reaction [APP protein results in increased abundance of Reactive Oxygen Species]; more ... | CTD | PMID:19464278 |
| quinine | multiple interactions | ISO | RGD:736021 | 6480464 | Quinine affects the reaction [APP protein binds to APP protein] | CTD | PMID:18537544 |
| resveratrol | multiple interactions | ISO | RGD:736021 | 6480464 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [resveratrol results in decreased expression of APP protein modified form]; more ... | CTD | PMID:20080969 |
| resveratrol | decreases response to substance | EXP | | 6480464 | resveratrol results in decreased susceptibility to APP protein | CTD | PMID:15134381 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol promotes the reaction [Catechin results in decreased susceptibility to APP protein] | CTD | PMID:15134381 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [APP protein results in increased expression of and results in increased activity of NOS2 protein]; more ... | CTD | PMID:16685418 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [APP protein results in increased acetylation of RELA protein] | CTD | PMID:16183991 |
| resveratrol | decreases secretion | ISO | RGD:736022 | 6480464 | resveratrol results in decreased secretion of APP protein mutant form | CTD | PMID:16162502 |
| resveratrol | decreases expression | ISO | RGD:736022 | 6480464 | resveratrol results in decreased expression of APP protein modified form | CTD | PMID:20080969 |
| resveratrol | decreases expression | ISO | RGD:736022 | 6480464 | resveratrol results in decreased expression of APP protein | CTD | PMID:22118570 |
| resveratrol | multiple interactions | ISO | RGD:736022 | 6480464 | resveratrol inhibits the reaction [APP protein results in increased phosphorylation of NFKBIA protein]; more ... | CTD | PMID:22118570 |
| resveratrol | increases degradation | ISO | RGD:736021 | 6480464 | resveratrol results in increased degradation of APP protein modified form | CTD | PMID:20080969 |
| resveratrol | decreases expression | ISO | RGD:736021 | 6480464 | resveratrol results in decreased expression of APP protein modified form | CTD | PMID:20080969 |
| resveratrol | multiple interactions | ISO | RGD:736021 | 6480464 | resveratrol inhibits the reaction [APP protein results in increased abundance of Superoxides] | CTD | PMID:16212921 |
| resveratrol | affects binding | ISO | RGD:736021 | 6480464 | resveratrol binds to [APP protein binds to APP protein] | CTD | PMID:17597573 |
| resveratrol | multiple interactions | ISO | RGD:736021 | 6480464 | PSMB5 protein affects the reaction [resveratrol results in decreased secretion of APP protein]; more ... | CTD | PMID:16162502 |
| rosiglitazone | multiple interactions | ISO | RGD:736022 | 6480464 | rosiglitazone inhibits the reaction [APP protein binds to APP protein] | CTD | PMID:19621015 |
| rosiglitazone | increases metabolic processing | ISO | RGD:736022 | 6480464 | rosiglitazone results in increased metabolism of APP protein | CTD | PMID:20336061 |
| rosiglitazone | multiple interactions | ISO | RGD:736021 | 6480464 | rosiglitazone promotes the reaction [LRP1 protein results in increased uptake of APP protein] | CTD | PMID:22040807 |
| rosiglitazone | multiple interactions | ISO | RGD:736021 | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone inhibits the reaction [Glycosylation End Products, Advanced results in increased expression of and results in increased secretion of APP protein]]; more ... | CTD | PMID:21765445 |
| S-adenosyl-L-homocysteine | increases expression | ISO | RGD:736022 | 6480464 | S-Adenosylhomocysteine results in increased expression of APP protein | CTD | PMID:22064374 |
| S-adenosyl-L-homocysteine | decreases methylation | ISO | RGD:736022 | 6480464 | S-Adenosylhomocysteine results in decreased methylation of APP promoter | CTD | PMID:19635394 |
| S-adenosyl-L-homocysteine | multiple interactions | ISO | RGD:736022 | 6480464 | Betaine inhibits the reaction [S-Adenosylhomocysteine results in decreased methylation of APP promoter]; more ... | CTD | PMID:19635394 |
| scopolamine | decreases cleavage | ISO | RGD:736022 | 6480464 | Scopolamine Hydrobromide results in decreased cleavage of APP protein | CTD | PMID:16423497 |
| scutellarin | multiple interactions | EXP | | 6480464 | scutellarin inhibits the reaction [APP protein binds to APP protein] | CTD | PMID:17323972 |
| selenium atom | decreases expression | ISO | RGD:736021 | 6480464 | Selenium results in decreased expression of APP mRNA | CTD | PMID:19244175 |
| selenomethionine | multiple interactions | EXP | | 6480464 | Selenomethionine inhibits the reaction [APP protein results in decreased expression of and results in decreased activity of GPX1 protein] | CTD | PMID:17280487 |
| sevoflurane | multiple interactions | ISO | RGD:736021 | 6480464 | APP protein modified form promotes the reaction [sevoflurane results in increased cleavage of CASP3 protein]; more ... | CTD | PMID:19433662 |
| sevoflurane | increases expression | ISO | RGD:736022 | 6480464 | sevoflurane results in increased expression of APP protein modified form | CTD | PMID:19433662 |
| sevoflurane | multiple interactions | ISO | RGD:736022 | 6480464 | sevoflurane promotes the reaction [CASP3 protein results in increased cleavage of APP protein] | CTD | PMID:19433662 |
| sevoflurane | increases expression | ISO | RGD:736021 | 6480464 | sevoflurane results in increased expression of APP protein modified form | CTD | PMID:19433662 |
| sevoflurane | affects cleavage | ISO | RGD:736021 | 6480464 | sevoflurane affects the cleavage of APP protein | CTD | PMID:19433662 |
| simvastatin | multiple interactions | ISO | RGD:736021 | 6480464 | oblimersen inhibits the reaction [Simvastatin results in decreased activity of APP protein alternative form]; more ... | CTD | PMID:17241114 |
| simvastatin | decreases activity | ISO | RGD:736021 | 6480464 | Simvastatin results in decreased activity of APP protein alternative form | CTD | PMID:17241114 |
| sirolimus | decreases expression | ISO | RGD:736021 | 6480464 | Sirolimus results in decreased expression of APP protein modified form | CTD | PMID:20542014 |
| sirolimus | increases expression | ISO | RGD:736021 | 6480464 | Sirolimus results in increased expression of APP protein modified form | CTD | PMID:20542014 |
| sirolimus | increases expression | ISO | RGD:736022 | 6480464 | Sirolimus results in increased expression of APP protein modified form | CTD | PMID:20542014 |
| sirolimus | decreases expression | ISO | RGD:736022 | 6480464 | Sirolimus results in decreased expression of APP protein modified form | CTD | PMID:20542014 |
| sodium azide | multiple interactions | ISO | RGD:736021 | 6480464 | [Sodium Azide co-treated with Deoxyglucose] affects the cleavage of and affects the localization of APP protein | CTD | PMID:17405930 |
| sodium dichromate | affects expression | EXP | | 6480464 | sodium bichromate affects the expression of APP mRNA | CTD | PMID:22110744 |
| staurosporine | multiple interactions | ISO | RGD:736021 | 6480464 | Staurosporine inhibits the reaction [Ginkgo biloba extract 761 inhibits the reaction [APP protein results in decreased phosphorylation of CREB1 protein]] | CTD | PMID:18001288 |
| staurosporine | multiple interactions | ISO | RGD:736021 | 6480464 | Staurosporine promotes the reaction [PSEN2 protein mutant form results in increased expression of APP protein] | CTD | PMID:12556443 |
| streptozocin | multiple interactions | EXP | | 6480464 | Memantine inhibits the reaction [Streptozocin results in increased expression of APP protein modified form] | CTD | PMID:21290839 |
| streptozocin | increases expression | ISO | RGD:736022 | 6480464 | Streptozocin results in increased expression of APP protein; more ... | CTD | PMID:21069392 |
| streptozocin | increases expression | EXP | | 6480464 | Streptozocin results in increased expression of APP protein modified form | CTD | PMID:21290839 |
| sulindac | multiple interactions | ISO | RGD:736021 | 6480464 | Sulindac inhibits the reaction [CDKN1A protein results in increased expression of APP mRNA] | CTD | PMID:15190207 |
| superoxide | multiple interactions | ISO | RGD:736021 | 6480464 | resveratrol inhibits the reaction [APP protein results in increased abundance of Superoxides] | CTD | PMID:16212921 |
| tamoxifen | affects expression | ISO | RGD:736022 | 6480464 | Tamoxifen affects the expression of APP mRNA | CTD | PMID:17555576 |
| tamoxifen | decreases expression | ISO | RGD:736022 | 6480464 | Tamoxifen results in decreased expression of APP mRNA | CTD | PMID:19400957 |
| tamoxifen | decreases expression | EXP | | 6480464 | Tamoxifen results in decreased expression of APP mRNA | CTD | PMID:19400957 |
| terbufos | increases methylation | ISO | RGD:736021 | 6480464 | terbufos results in increased methylation of APP promoter | CTD | PMID:22847954 |
| tert-butyl hydroperoxide | decreases expression | ISO | RGD:736021 | 6480464 | tert-Butylhydroperoxide results in decreased expression of APP mRNA | CTD | PMID:12419474 |
| testosterone enanthate | affects expression | ISO | RGD:736021 | 6480464 | testosterone enanthate affects the expression of APP mRNA | CTD | PMID:17440010 |
| tetrachloromethane | decreases expression | ISO | RGD:736022 | 6480464 | Carbon Tetrachloride results in decreased expression of APP mRNA | CTD | PMID:17484886 |
| tetrahydrocurcumin | multiple interactions | ISO | RGD:736021 | 6480464 | tetrahydrocurcumin inhibits the reaction [APP protein binds to APP protein] | CTD | PMID:19715544 |
| tetrathiomolybdate(2-) | multiple interactions | ISO | RGD:736021 | 6480464 | [tetrathiomolybdate binds to APP 5' UTR] which results in decreased expression of APP protein; more ... | CTD | PMID:15681799 PMID:15681799 |
| tetrathiomolybdate(2-) | affects binding | ISO | RGD:736021 | 6480464 | tetrathiomolybdate binds to APP 5' UTR | CTD | PMID:15681799 |
| thiethylperazine | multiple interactions | ISO | RGD:736022 | 6480464 | [Thiethylperazine results in increased activity of ABCC1 protein] which results in increased export of APP protein | CTD | PMID:21881209 |
| thiourea | increases uptake | ISO | RGD:736022 | 6480464 | Thiourea results in increased uptake of APP protein modified form | CTD | PMID:20637185 |
| toluene | affects expression | EXP | | 6480464 | Toluene affects the expression of APP mRNA | CTD | PMID:21827849 |
| trans-resveratrol | multiple interactions | ISO | RGD:736021 | 6480464 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [resveratrol results in decreased expression of APP protein modified form]; more ... | CTD | PMID:20080969 |
| trans-resveratrol | decreases response to substance | EXP | | 6480464 | resveratrol results in decreased susceptibility to APP protein | CTD | PMID:15134381 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol promotes the reaction [Catechin results in decreased susceptibility to APP protein] | CTD | PMID:15134381 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [APP protein results in increased expression of and results in increased activity of NOS2 protein]; more ... | CTD | PMID:16685418 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [APP protein results in increased acetylation of RELA protein] | CTD | PMID:16183991 |
| trans-resveratrol | decreases secretion | ISO | RGD:736022 | 6480464 | resveratrol results in decreased secretion of APP protein mutant form | CTD | PMID:16162502 |
| trans-resveratrol | decreases expression | ISO | RGD:736022 | 6480464 | resveratrol results in decreased expression of APP protein modified form | CTD | PMID:20080969 |
| trans-resveratrol | decreases expression | ISO | RGD:736022 | 6480464 | resveratrol results in decreased expression of APP protein | CTD | PMID:22118570 |
| trans-resveratrol | multiple interactions | ISO | RGD:736022 | 6480464 | resveratrol inhibits the reaction [APP protein results in increased phosphorylation of NFKBIA protein]; more ... | CTD | PMID:22118570 |
| trans-resveratrol | increases degradation | ISO | RGD:736021 | 6480464 | resveratrol results in increased degradation of APP protein modified form | CTD | PMID:20080969 |
| trans-resveratrol | decreases expression | ISO | RGD:736021 | 6480464 | resveratrol results in decreased expression of APP protein modified form | CTD | PMID:20080969 |
| trans-resveratrol | multiple interactions | ISO | RGD:736021 | 6480464 | resveratrol inhibits the reaction [APP protein results in increased abundance of Superoxides] | CTD | PMID:16212921 |
| trans-resveratrol | affects binding | ISO | RGD:736021 | 6480464 | resveratrol binds to [APP protein binds to APP protein] | CTD | PMID:17597573 |
| trans-resveratrol | multiple interactions | ISO | RGD:736021 | 6480464 | PSMB5 protein affects the reaction [resveratrol results in decreased secretion of APP protein]; more ... | CTD | PMID:16162502 |
| trichlorfon | increases secretion | ISO | RGD:736021 | 6480464 | Trichlorfon results in increased secretion of APP protein alternative form | CTD | PMID:11526466 |
| trichlorfon | affects metabolic processing | EXP | | 6480464 | Trichlorfon affects the metabolism of APP protein | CTD | PMID:10773217 |
| trichlorfon | affects cleavage | EXP | | 6480464 | Trichlorfon affects the cleavage of APP protein | CTD | PMID:11099780 PMID:11822883 |
| trimellitic anhydride | decreases expression | ISO | RGD:736022 | 6480464 | trimellitic anhydride results in decreased expression of APP mRNA | CTD | PMID:19042947 |
| troglitazone | increases expression | ISO | RGD:736021 | 6480464 | troglitazone results in increased expression of APP mRNA | CTD | PMID:19140230 |
| uranium atom | affects expression | ISO | RGD:736021 | 6480464 | Uranium affects the expression of APP mRNA | CTD | PMID:15672453 |
| valproic acid | increases expression | ISO | RGD:736022 | 6480464 | Valproic Acid results in increased expression of APP mRNA | CTD | PMID:22045034 |
| zinc atom | multiple interactions | ISO | RGD:736021 | 6480464 | Clioquinol inhibits the reaction [Zinc results in increased secretion of APP protein alternative form] | CTD | PMID:16648635 |
| zinc atom | increases expression | EXP | | 6480464 | Zinc deficiency results in increased expression of APP mRNA | CTD | PMID:19111725 |
| zinc atom | multiple interactions | ISO | RGD:736022 | 6480464 | [APP protein co-treated with Zinc] results in increased degradation of GPC1 protein modified form | CTD | PMID:15677459 |
| zinc atom | increases degradation | ISO | RGD:736021 | 6480464 | Zinc results in increased degradation of APP protein modified form | CTD | PMID:18068270 |
| zinc atom | multiple interactions | ISO | RGD:736021 | 6480464 | Zinc inhibits the reaction [APP protein modified form results in increased reduction of Copper]; more ... | CTD | PMID:12572668 |
| zinc atom | affects binding | ISO | RGD:736021 | 6480464 | APP protein modified form binds to Zinc | CTD | PMID:16404590 |
| zinc atom | multiple interactions | EXP | | 6480464 | [Zinc promotes the reaction [APP protein binds to APP protein]] which affects the transport of Potassium | CTD | PMID:16674922 |
| zinc atom | increases secretion | ISO | RGD:736021 | 6480464 | Zinc results in increased secretion of APP protein alternative form | CTD | PMID:16648635 |
| zinc atom | affects binding | ISO | RGD:736021 | 6480464 | Zinc binds to APP protein alternative form | CTD | PMID:15699049 |
| zinc atom | affects binding | ISO | RGD:736021 | 6480464 | Zinc binds to APP protein | CTD | PMID:16266835 PMID:17119284 |
| zinc atom | multiple interactions | ISO | RGD:736021 | 6480464 | Zinc binds to and affects the folding of APP protein | CTD | PMID:16325427 |
| zinc(0) | multiple interactions | ISO | RGD:736021 | 6480464 | Clioquinol inhibits the reaction [Zinc results in increased secretion of APP protein alternative form] | CTD | PMID:16648635 |
| zinc(0) | multiple interactions | ISO | RGD:736021 | 6480464 | Zinc binds to and affects the folding of APP protein | CTD | PMID:16325427 |
| zinc(0) | affects binding | ISO | RGD:736021 | 6480464 | Zinc binds to APP protein | CTD | PMID:16266835 PMID:17119284 |
| zinc(0) | affects binding | ISO | RGD:736021 | 6480464 | Zinc binds to APP protein alternative form | CTD | PMID:15699049 |
| zinc(0) | increases secretion | ISO | RGD:736021 | 6480464 | Zinc results in increased secretion of APP protein alternative form | CTD | PMID:16648635 |
| zinc(0) | multiple interactions | EXP | | 6480464 | [Zinc promotes the reaction [APP protein binds to APP protein]] which affects the transport of Potassium | CTD | PMID:16674922 |
| zinc(0) | affects binding | ISO | RGD:736021 | 6480464 | APP protein modified form binds to Zinc | CTD | PMID:16404590 |
| zinc(0) | multiple interactions | ISO | RGD:736021 | 6480464 | Zinc inhibits the reaction [APP protein modified form results in increased reduction of Copper]; more ... | CTD | PMID:12572668 |
| zinc(0) | increases degradation | ISO | RGD:736021 | 6480464 | Zinc results in increased degradation of APP protein modified form | CTD | PMID:18068270 |
| zinc(0) | multiple interactions | ISO | RGD:736022 | 6480464 | [APP protein co-treated with Zinc] results in increased degradation of GPC1 protein modified form | CTD | PMID:15677459 |
| zinc(0) | increases expression | EXP | | 6480464 | Zinc deficiency results in increased expression of APP mRNA | CTD | PMID:19111725 |